SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
156 hedge funds and large institutions have $747M invested in SANGAMO THERAPEUTICS INC in 2014 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 56 increasing their positions, 34 reducing their positions, and 24 closing their positions.
2,333% more call options, than puts
Call options by funds: $199M | Put options by funds: $8.16M
65% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 34
46% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 24
8% more funds holding
Funds holding: 145 → 156 (+11)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
14% less capital invested
Capital invested by funds: $869M → $747M (-$122M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$13M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.83M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.83M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$3.2M |
| 5 |
CNB
City National Bank
Beverly Hills,
California
|
+$3.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$35M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$4.67M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.8M |
SGMO Hedge Fund Activity: Q2 2014 in Review
156 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2014, worth a combined $747M — down 14% from $869M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new SGMO positions and 24 closed out — a net gain of 11 holders — while 56 added to existing stakes and 34 trimmed.
The largest buyer was Frontier Capital Management, adding an estimated $13M. The largest seller was RA Capital Management, cutting an estimated $35M.
- 156 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2014, up from 145 in Q1 2014.
- Funds reported $747M of SANGAMO THERAPEUTICS INC stock for Q2 2014, down 14% quarter-over-quarter.
- 35 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2014 and 24 closed out, a net change of +11 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q2 2014 was Frontier Capital Management, an estimated $13M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q2 2014 was RA Capital Management, an estimated $35M sold.
Based on aggregated 13F filings for Q2 2014.